Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: Results of a randomised single heterologous booster dose study at 15 months.
Vaccine
; 31(2): 436-7, 2013 Jan 02.
Article
en En
| MEDLINE
| ID: mdl-23387064
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Vacunas contra la Influenza
/
Subtipo H5N1 del Virus de la Influenza A
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Humans
Idioma:
En
Revista:
Vaccine
Año:
2013
Tipo del documento:
Article